CVS Health said stockholders approved amendments to its 2017 Incentive Compensation Plan at the annual meeting held on May 16, 2024. The amendments mainly increase the number of common shares available for issuance under the plan by 33.5 million shares.

1. 01

   CVS Health said stockholders approved amendments to its 2017 Incentive Compensation Plan at the annual meeting held on May 16, 2024. The amendments mainly increase the number of common shares available for issuance under the plan by 33.5 million shares.

2. 02

   The company said stockholders approved the proposal to increase shares available under the 2017 ICP (Item 4), with 919,806,818 votes for, 38,826,632 against, 2,373,949 abstentions and 147,663,985 broker non-votes.

3. 03

   The company said holders of 1,108,671,384 shares of common stock attended the annual meeting in person or by proxy, constituting a quorum. 12 director nominees were elected for one-year terms.

4. 04

   CVS Health said stockholders approved the ratification of Ernst & Young LLP as its independent registered public accounting firm for 2024 and the advisory vote on executive compensation. The company also said 4 stockholder proposals (Items 5, 6, 7 and 8) were not approved.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.